CLICK HERE to sign up to receive updates. You can customize your communication preferences at any time.
© 2021 Medical Affairs Professional Society.All Rights Reserved.
On behalf of MAPS and IFAPP Academy, we would like to introduce you to the Introduction to Medical Affairs in Medicines Development Course. This course was designed for the Medical Affairs professional who wants to further learn the fundamentals of Medicines Development and how the various Medical Affairs functions contribute to bringing better medicines to the marketplace, meeting the patient needs and improving health in the general population.
This course was adapted from the ongoing professional certification program the IFAPP Academy has developed with King’s College London. It gathers together experts from the pharmaceutical industry, regulatory agencies and academic institutions to offer the latest advances in all areas of Medicines Development as well as tips for the effective practice of the Medical Affairs function through state-of-the art interactive distance learning.
To earn the Introduction to Medical Affairs in Medicines Development certificate of completion, a student must complete and pass the course, completing 10 Lessons + 4 Webinars + the Final Assessment. A student will need to be self-directed, self-motivated, and well-organized in their studies and in completing the course work.
3 – 5 hours per week
1.5 – 2.5 hours per webinar
1-hour exam + additional study time
Course syllabus
Faculty: Kenneth Kaitin
Title: Director Tufts Center for the Study of Drug Development
Professor Tufts University School of Medicine, USA
Faculty: Pol Vandenbroucke
Title: Chief Medical Officer Hospital Business Unit
Company: Pfizer, USA
Faculty: Sandor Kerpel-Fronius
Title: Professor at Semmelweis University Department of Pharmacology and Pharmacotherapy Budapest, Hungary
Faculty: Laurent Pacheco
Title: Managing Director, Value Access & HEOR
Company: Syneos, UK
Faculty: Xavier Luria
Title: Chair and Senior Consultant
Company: Drug development and Regulation, Spain
Faculty: Sandor Kerpel-Fronius
Title: Professor at Semmelweis University Department of Pharmacology and Pharmacotherapy Budapest, Hungary
Faculty: Tamas Suto
Title: SVP, Global Head of Oncology Medical Affairs, Merck EMD Serono
Company: Merck EMD Serono, Germany
Faculty: Nikolas Karkanias
Title: Senior Director Global Digital Partner Hospital and Rare Diseases Business Unit
Company: Pfizer, USA
Faculty: Xavier Luria
Title: Chair and Senior Consultant
Company: Drug development and Regulation. Spain
Faculty: Rozlin Schneider
Title: Vice President Scientific, Medical and Patient Affairs of Pharmaceutical Medicine
Company: Theravance Biopharma. USA
WEBINARS
Faculty: Kenneth Kaitin
Title: Director Tufts Center for the Study of Drug Development
Professor Tufts University School of Medicine, USA
Faculty: John Kelton
Title: Medical Director Oncology Biosimilars
Company: Pfizer, USA
Faculty: Sandor Kerpel-Fronius
Title: Professor at Semmelweis University Department of Pharmacology and Pharmacotherapy Budapest, Hungary
Faculty: Nikolas Karkanias
Title: Senior Director Global Digital Partner Hospital and Rare Diseases Business Unit
Company: Pfizer, USA